The Billion-Euro European Biotech Companies in 2022
Here’s a list of the public European biotech companies that are worth more than a…
Here’s a list of the public European biotech companies that are worth more than a…
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
Clinical and regulatory setbacks have left the star biotech duo Gilead and Galapagos smarting and…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
Development of MorphoSys, Galapagos, and Novartis’ first-in-class antibody drug has been discontinued during a phase…
Gilead has launched a 10-year collaboration with the Belgo-Dutch biotech Galapagos, paying at least €4.5B…
Galapagos is an undeniable success story. Set up in 1999, it is now one of…
We’ve put together a list of the best biotech companies in Europe to celebrate their…
Galapagos has released positive data from two phase III trials testing its flagship drug candidate,…
What does it take to be a successful biotech entrepreneur? I put this and other…
Phase I results show promise for a new treatment for atopic dermatitis that may become…